Zobrazeno 1 - 10
of 70
pro vyhledávání: '"K Winterling"'
Publikováno v:
65th Annual Meeting of the Society of Thrombosis and Haemostasis Research.
Publikováno v:
Section 4: Clinical Pharmacy Services.
Background Human normal immunoglobulin preparations for intravenous application (IVIG) such as Biotest’s Intratect were initially developed as substitution therapy for primary and secondary immunodeficiencies. Over time the clinical use has broaden
Publikováno v:
Science meets clinical practice.
Publikováno v:
Annals of the Rheumatic Diseases. 79:454.3-454
Background:Pegloticase is a PEGylated biologic for uncontrolled gout that has well-established efficacy. However, anti-drug antibody (ADA) development causes many patients to discontinue treatment before receiving the full therapeutic course.1ADAs bi
Autor:
Gerhardus Venema, D Vansinderen, Bert Jan Haijema, K Winterling, Leendert W. Hamoen, Jan Kooistra
Publikováno v:
Molecular Microbiology, 22(1), 75-85. Wiley
It has been hypothesized that the dinR gene product of Bacillus subtilis acts as a repressor of the SOS regulon by binding to DNA sequences located upstream of SOS genes, including dinR and recA. Following activation as a result of DNA damage, RecA i
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Autor:
Broadwell, Aaron1 (AUTHOR), Albert, John A.2 (AUTHOR), Padnick-Silver, Lissa3 (AUTHOR), LaMoreaux, Brian3 (AUTHOR) blamoreaux@horizontherapeutics.com
Publikováno v:
Rheumatology & Therapy. Dec2022, Vol. 9 Issue 6, p1549-1558. 10p.
Autor:
Tan, Kelly R.1 krtan@email.unc.edu, Fredrickson, Barbara2, Santos Jr., Hudson3, Wood, William4, Schwartz, Todd A.5, Mayer, Deborah K.6
Publikováno v:
Oncology Nursing Forum. Nov2022, Vol. 49 Issue 6, p541-551. 11p. 1 Diagram, 3 Charts, 1 Graph.
Autor:
Kisch AM; Department of Haematology, Oncology and Radiation Physics, Skåne University Hospital, Lund, Sweden. annika.kisch@med.lu.se.; Institute of Health Sciences, Lund University, Lund, Sweden. annika.kisch@med.lu.se., Bergkvist K; Department of Neurobiology, Care Sciences and Society, Karolinska Institutet, Stockholm, Sweden.; Department of Care Science, Sophiahemmet University, Stockholm, Sweden., Adalsteinsdóttir S; Medical Unit CAST, Comprehensive Cancer Centre, Karolinska University Hospital, Stockholm, Sweden., Wendt C; Department of Haematology, Oncology and Radiation Physics, Skåne University Hospital, Lund, Sweden., Alvariza A; Department of Health Care Sciences, Palliative Research Centre, Marie Cederschiöld University, Stockholm, Sweden.; Capio Palliative Care, Dalen hospital, Stockholm, Sweden., Winterling J; Department of Neurobiology, Care Sciences and Society, Karolinska Institutet, Stockholm, Sweden.; Medical Unit HHLH, Comprehensive Cancer Centre, Karolinska University Hospital, Stockholm, Sweden.
Publikováno v:
Supportive care in cancer : official journal of the Multinational Association of Supportive Care in Cancer [Support Care Cancer] 2022 Nov; Vol. 30 (11), pp. 9039-9047. Date of Electronic Publication: 2022 Aug 11.